Using an animal model of diabetic nephropathy, Otomo and colleagues (Otomo et al., 2020) observed that SGLT2 inhibition suppressed O-GlcNAcylation of megalin, contributing to megalin internalization. This evidence concerns the gene LRP2 and diabetic kidney disease.